Barclays’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-566
| Closed | – | – | 4333 |
|
|
2021
Q1 | $0 | Buy |
+566
| New | – | ﹤0.01% | 4015 |
|
|
2020
Q2 | – | Sell |
-27,669
| Closed | -$24K | – | 4059 |
|
|
2020
Q1 | $24K | Sell |
27,669
-56,065
| -67% | -$48.6K | ﹤0.01% | 3348 |
|
|
2019
Q4 | $137K | Buy |
83,734
+42,446
| +103% | +$69.4K | ﹤0.01% | 3338 |
|
|
2019
Q3 | $46K | Sell |
41,288
-26,388
| -39% | -$29.4K | ﹤0.01% | 3705 |
|
|
2019
Q2 | $83K | Buy |
67,676
+51,536
| +319% | +$63.2K | ﹤0.01% | 3677 |
|
|
2019
Q1 | $23K | Buy |
16,140
+12,140
| +304% | +$17.3K | ﹤0.01% | 3885 |
|
|
2018
Q4 | $5K | Sell |
4,000
-23,905
| -86% | -$29.9K | ﹤0.01% | 3747 |
|
|
2018
Q3 | $38K | Sell |
27,905
-5,020
| -15% | -$6.84K | ﹤0.01% | 3813 |
|
|
2018
Q2 | $75K | Buy |
32,925
+4,083
| +14% | +$9.3K | ﹤0.01% | 3178 |
|
|
2018
Q1 | $44K | Buy |
28,842
+18,430
| +177% | +$28.1K | ﹤0.01% | 3558 |
|
|
2017
Q4 | $7K | Buy |
10,412
+9,549
| +1,106% | +$6.42K | ﹤0.01% | 3870 |
|
|
2017
Q3 | $1K | Buy |
863
+743
| +619% | +$861 | ﹤0.01% | 3975 |
|
|
2017
Q2 | $0 | Sell |
120
-734
| -86% | – | ﹤0.01% | 4188 |
|
|
2017
Q1 | $3K | Sell |
854
-476
| -36% | -$1.67K | ﹤0.01% | 3742 |
|
|
2016
Q4 | $6K | Buy |
1,330
+366
| +38% | +$1.65K | ﹤0.01% | 3414 |
|
|
2016
Q3 | $2K | Buy |
+964
| New | +$2K | ﹤0.01% | 3658 |
|
|
2016
Q2 | – | Sell |
-1,164
| Closed | -$2K | – | 3968 |
|
|
2016
Q1 | $2K | Buy |
1,164
+1,103
| +1,808% | +$1.9K | ﹤0.01% | 3247 |
|
|
2015
Q4 | $0 | Sell |
61
-131
| -68% | – | ﹤0.01% | 3935 |
|
|
2015
Q3 | $1K | Sell |
192
-510
| -73% | -$2.66K | ﹤0.01% | 3819 |
|
|
2015
Q2 | $4K | Sell |
702
-3
| -0.4% | -$17 | ﹤0.01% | 3737 |
|
|
2015
Q1 | $5K | Buy |
+705
| New | +$5K | ﹤0.01% | 3701 |
|